OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for January, 2014

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2014-01-31 12:15 Two biotech IPOs blast off, spurring dreams--and fears--of an attempted gold rush and more... 2014-01-31 00:15 Is AbbVie (ABBV) Poised to Beat Earnings Estimates? and more... 2014-01-30 12:15 New British biotech firm to tap gene therapy for blindness and more... 2014-01-30 00:15 Novartis expects a generic of Diovan to finally arrive in April and more... 2014-01-29 12:15 Novartis keeps CEO pay steady, but incoming chairman pay drops and more... 2014-01-29 00:15 Earnings Preview: Amgen looks to repeat strong Neupogen sales in Q4 and more... 2014-01-28 12:15 Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin and more... 2014-01-28 00:15 Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk and more... 2014-01-27 12:15 Geron Shares React to Imetelstat Mayo Study Update and more... 2014-01-27 00:15 Teva Plunge Short-Lived to Bernstein Amid Board Overhaul and more... 2014-01-26 12:15 GlaxoSmithKline's Eperzan Gets Closer to Launch and more... 2014-01-26 00:15 Teva?â?ó?éÔé¼?éÔäós Laquinimod MS Pill Fails to Win EU Agency Backing and more... 2014-01-25 12:15 Big Pharmas Battle For The Billion-Dollar Melanoma Market and more... 2014-01-25 00:15 Ariad shares jump nearly 30% on rumors of Big Pharma takeover and more... 2014-01-24 12:15 Bristol-Myers sees 'encouraging' trends for Eliquis with hopes of expansion and more... 2014-01-24 00:15 Merck Gets Good News On New Heart Attack Therapy and more... 2014-01-23 12:15 Ariad Joins Rumor Mill: Hope May Trump Reality and more... 2014-01-23 00:15 Amarin Tumbles after DMEP Decision and more... 2014-01-22 12:15 EMA Bests FDA in 2013 New Drug Approval Numbers and more... 2014-01-22 00:15 Abbott Faces New Trial Over Gay Juror Exclusion in HIV drug pricing trial and more... 2014-01-21 12:15 Despite Earnings Beat Johnson & Johnson Shares Sag Thanks To Modest 2014 Outlook and more... 2014-01-21 00:15 Positive Oncology News Lifts OncoMed and more... 2014-01-20 12:15 What?â?ó?éÔé¼?éÔäós In Store for Biotechs at this Year?â?ó?éÔé¼?éÔäós CEO & Investor Conference and more... 2014-01-20 00:15 GCVRZ: Betting On The Sales Of Lemtrada In A Moving MS Drug Market and more... 2014-01-18 12:15 Big Pharma may cut South African investment in generics row and more... 2014-01-18 00:15 Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs and more... 2014-01-17 12:15 FDA Approvals Strong in 2013, but Far From Highs of 2012 and more... 2014-01-17 00:15 FDA advisory panel rejects J&J drug for acute coronary syndrome and more... 2014-01-16 12:15 Prospects Bright at Alexion Pharma and more... 2014-01-16 00:15 FDA advisory panel backs Merck's blood clot-preventing drug and more... 2014-01-15 12:15 Drug buyers sue Novo Nordisk over 'wrongful' delays to diabetes generic and more... 2014-01-15 00:15 Teva sees U.S. approval of three times weekly Copaxone soon and more... 2014-01-14 12:15 The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians and more... 2014-01-14 00:15 Lilly buys back a migraine therapy from Arteaus Therapeutics and more... 2014-01-13 12:15 J.P. Morgan Healthcare Confab Live Blog: Day One and more... 2014-01-12 12:15 Dr Reddy's, Zydus, Cadila seek more time for their SEZ units (in India) and more... 2014-01-11 12:15 The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10 and more... 2014-01-11 00:15 Amgen spinoff Atara cranks its Series B up to $52M and more... 2014-01-10 12:15 Google X Staff Meet With FDA Pointing Toward New Device and more... 2014-01-10 00:15 Merck Gets FDA Approval For New Formulation Of Isentress and more... 2014-01-09 12:15 US Pharma Challenges 2014 and more... 2014-01-09 00:15 Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval and more... 2014-01-08 12:15 This Overvalued Biotech is in Danger of Plummeting as Much as 30% and more... 2014-01-08 00:15 Lilly is carving up to $1B out of its struggling R&D division and more... 2014-01-07 12:15 The Twitterverse's Biotech Stock Picks for 2014 and more... 2014-01-07 00:15 Obesity Stocks Focus on Approvals As Arena Pharmaceuticals Goes Global and more... 2014-01-06 12:15 J&J's Synthes wins round in spat with ex-sales rep and more... 2014-01-06 00:15 RNAi Developer Dicerna Pharmaceuticals to IPO and more... 2014-01-05 00:15 Bayer's hot-selling Eylea runs into a roadblock in its home market and more... 2014-01-04 00:15 Is Tamiflu Worth It? Britain Reconsiders a Best-Selling Flu Remedy and more... 2014-01-03 00:15 U.S. domination of global biomedical R&D slips as Asian budgets swell and more... 2014-01-02 12:15 Sanofi Will Share Clinical Trial Data, But There Is A Caveat and more... 2014-01-02 00:15 4 Biggest Biotech Disasters Of 2013 2014-01-01 12:15 Gilead Hepatitis C Pill Leads 27 New U.S. Drug Approvals and more... 2014-01-01 00:15 Biotech M&A Growth Trend To Continue and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe